|25 August, 2019

DHA signs MOUs with two medical centres to enhance long-term patient care

The MoU aims forfuture cooperation between the two parties regarding the transfer of long-term patients to follow-up their treatment and rehabilitation according to their health history, and clinical requirements

DHA signs MOUs with two medical centres to enhance long-term patient care

The Dubai Health Authority (DHA) signed a Memorandum of Understanding (MOU) with Cambridge Medical and Rehabilitation Centre and NMC Provita International Medical Centre with the aim of facilitating the transfer of long-term patients to the two centres for treatment and rehabilitation. 

The first MoU was signed by Dr Younis Kazim, CEO of the Dubai Healthcare Cooperation at the DHA and Mr Fernando Parker, Director of Operations at NMC Provita International Medical Centre. 

The second MoU was signed by Dr Kazim and Dr Howard S. Podolsky, Group CEO of Cambridge Medical Rehabilitation Centre.  

The MoU aims forfuture cooperation between the two parties regarding the transfer of long-term patients to follow-up their treatment and rehabilitation according to their health history, and clinical requirements.

Commenting on the MoU, Dr Kazim said that the DHA looks forward to collaborating with both centres with the aim of providing quality treatment and rehabilitation care for long-term patients. 

He emphasised the importance of the MoUs as they would greatly contribute to reducing the burden on hospitals by transferring long term patients to centres that are specialised in the field and provide quality treatment that are on par with international standards, hence freeing beds at DHA hospitals to cater to acute patients. 

Dr Kazim emphasized that both centres were chosen after meeting international criteria and after careful evaluation to ensure that patients are receiving the best level of care possible. 

Dr Kazim added that the DHA constantly strives to strengthen its relations with international health facilities to promote investment and exchange experiences in line with the authority’s strategy. 

Both parties expressed their keenness to collaborate with the authority to provide patients with quality healthcare services.   


For further information, please contact:
Mahmoud Al Ali
Kamakshi Gupta and Noor Nazzal
Head of Media
Communications Analysts- Media Dept.
Dubai Health Authority
Dubai Health Authority
myalali@dha.gov.ae 
klgupta@dha.gov.ae nnnazzal@dha.gov.ae 
+9714 219 7260
+9714 2197455

About the Dubai Health Authority: 

The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement. 

Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.

In May 2018, H.H Sheikh Mohammed, issued Law No. (6) Of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.

According to the Law, DHA will ensure the availability of quality medical insurance programmes, improve medical services according to the highest international standards, contribute to providing attractive infrastructure for investments, boost Dubai’s position as a global hub for medical tourism and medical education, encourage innovation in the healthcare sector and improve preventive healthcare measures.

The Law specified DHA’s responsibilities to include preparing a comprehensive strategic plan for Dubai’s healthcare sector, conducting studies and surveys to define Dubai’s future needs and matching the results with future investments, licensing and monitoring medical workers and medical facilities according to DHA’s approved regulations. Its responsibilities also include regulating medical education and medical research in collaboration with competent local and international authorities and drafting and developing policies and procedures for the healthcare sector in Dubai.

The Law authorises DHA to regulate and approve the prices of medical services offered by private healthcare facilities in Dubai and ensure the quality of medical services. DHA is also responsible for regulating and facilitating the sending of patients for specialised medical treatment to healthcare facilities both within and outside the country, regulating and overseeing medical tourism in collaboration with concerned authorities, managing and developing policies that govern medical insurance and regulating medical advertising in Dubai.

H.H Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.

Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services. 

In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres. 

For more information, visit DHA’s website: www.dha.gov.ae 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases